nortriptyline has been researched along with Neoplasms in 6 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| "Nortriptyline promotes cell acidification and suppresses macropinocytosis, providing a link between fatty acid uptake and tumor progression." | 1.91 | Stopping the fat: Repurposing an antidepressant for cancer treatment. ( Bhullar, D; Commisso, C, 2023) |
| "Data collected included demographics, cancer and co-morbid diagnoses, and compliance to antidepressant medication using medication possession ratio (MPR) by patient, medication class, and individual agents." | 1.37 | Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer center setting. ( Adamus, A; Arbuckle, R; DaCosta Byfield, S; Feng, C; Hung, F; Lal, LS; Miller, LA; Zhuang, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Chu, Q | 2 |
| An, J | 2 |
| Liu, P | 2 |
| Song, Y | 2 |
| Zhai, X | 2 |
| Yang, R | 2 |
| Niu, J | 2 |
| Yang, C | 2 |
| Li, B | 2 |
| Bhullar, D | 1 |
| Commisso, C | 1 |
| Lal, LS | 1 |
| Hung, F | 1 |
| Feng, C | 1 |
| Zhuang, A | 1 |
| DaCosta Byfield, S | 1 |
| Miller, LA | 1 |
| Adamus, A | 1 |
| Arbuckle, R | 1 |
| Taube, AW | 1 |
| Jenkins, C | 1 |
| Bruera, E | 1 |
2 reviews available for nortriptyline and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
4 other studies available for nortriptyline and Neoplasms
| Article | Year |
|---|---|
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.
Topics: Animals; Antidepressive Agents, Tricyclic; Drug Repositioning; Fatty Acids; Fatty Liver; Liver; Meta | 2023 |
Stopping the fat: Repurposing an antidepressant for cancer treatment.
Topics: Antidepressive Agents; Fatty Acids; Humans; Neoplasms; Nortriptyline | 2023 |
Evaluation of medication compliance in patients on antidepressants at an outpatient tertiary cancer center setting.
Topics: Aged; Antidepressive Agents; Cancer Care Facilities; Depression; Electronic Health Records; Female; | 2011 |
Is a "palliative" patient always a palliative patient? Two case studies.
Topics: Acute Kidney Injury; Adaptation, Psychological; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-In | 1997 |